IT1249047B - Composizione farmaceutica per il trattamento della cataratta - Google Patents

Composizione farmaceutica per il trattamento della cataratta

Info

Publication number
IT1249047B
IT1249047B ITMI910456A ITMI910456A IT1249047B IT 1249047 B IT1249047 B IT 1249047B IT MI910456 A ITMI910456 A IT MI910456A IT MI910456 A ITMI910456 A IT MI910456A IT 1249047 B IT1249047 B IT 1249047B
Authority
IT
Italy
Prior art keywords
treatment
cataract
pharmaceutical composition
cysteine
acetyl
Prior art date
Application number
ITMI910456A
Other languages
English (en)
Inventor
Francesco Santangelo
Giorgio Bertolini
Franco Pellacini
Luciano Soldati
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Priority to ITMI910456A priority Critical patent/IT1249047B/it
Publication of ITMI910456A0 publication Critical patent/ITMI910456A0/it
Priority to DE69218816T priority patent/DE69218816T2/de
Priority to EP92101873A priority patent/EP0499882B1/en
Priority to AT92101873T priority patent/ATE151288T1/de
Priority to JP08511392A priority patent/JP3457687B2/ja
Publication of ITMI910456A1 publication Critical patent/ITMI910456A1/it
Priority to US07/971,577 priority patent/US5519054A/en
Application granted granted Critical
Publication of IT1249047B publication Critical patent/IT1249047B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Sono descritte composizioni farmaceutiche per il trattamento della cataratta contenenti precursori biologici della N-acetil-L-cisteina.
ITMI910456A 1991-02-21 1991-02-21 Composizione farmaceutica per il trattamento della cataratta IT1249047B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITMI910456A IT1249047B (it) 1991-02-21 1991-02-21 Composizione farmaceutica per il trattamento della cataratta
DE69218816T DE69218816T2 (de) 1991-02-21 1992-02-05 N-acetyl-cysteine Derivate enthaltende pharmazeutische Zusammensetzung zur Behandlung von Katarakt
EP92101873A EP0499882B1 (en) 1991-02-21 1992-02-05 Pharmaceutical compositions containing N-acetyl-cysteine derivatives useful for the treatment of cataracts
AT92101873T ATE151288T1 (de) 1991-02-21 1992-02-05 N-acetyl-cysteine derivate enthaltende pharmazeutische zusammensetzung zur behandlung von katarakt
JP08511392A JP3457687B2 (ja) 1991-02-21 1992-02-21 白内障治療用薬剤
US07/971,577 US5519054A (en) 1991-02-21 1992-11-05 Pharmaceutical compositions containing N-acetyl-cysteine derivatives useful for the treatment of cataract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910456A IT1249047B (it) 1991-02-21 1991-02-21 Composizione farmaceutica per il trattamento della cataratta

Publications (3)

Publication Number Publication Date
ITMI910456A0 ITMI910456A0 (it) 1991-02-21
ITMI910456A1 ITMI910456A1 (it) 1992-08-21
IT1249047B true IT1249047B (it) 1995-02-11

Family

ID=11358690

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI910456A IT1249047B (it) 1991-02-21 1991-02-21 Composizione farmaceutica per il trattamento della cataratta

Country Status (6)

Country Link
US (1) US5519054A (it)
EP (1) EP0499882B1 (it)
JP (1) JP3457687B2 (it)
AT (1) ATE151288T1 (it)
DE (1) DE69218816T2 (it)
IT (1) IT1249047B (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1258781B (it) * 1992-01-16 1996-02-29 Zambon Spa Composizione farmaceutica oftalmica contenente n-acetilcisteina e polivinilalcol
ATE315939T1 (de) * 1993-11-19 2006-02-15 Univ Sydney Verfahren zur prophylaxe oder kontrolle des katarakts
US5686450A (en) * 1995-06-07 1997-11-11 Alcon Laboratories, Inc. Use of N,N'-bis(mercaptoacetyl) hydrazine derivatives as anticataract agents
WO1997026879A1 (en) * 1996-01-26 1997-07-31 The United States Of America, Represented By The Secretary, Department Of Health And Human Services, The National Institutes Of Health Hydroxylamine compositions for the prevention or retardation of cataracts
WO1999049895A2 (en) * 1998-03-31 1999-10-07 Johnson And Johnson Consumer Companies, Inc. Method for increasing the permeability of horny human tissue
US6231875B1 (en) 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
WO2001024794A1 (en) * 1999-08-09 2001-04-12 Webb-Waring Institute For Biomedical Research A method for the treatment of ocular oxidative stress
FR2811550B1 (fr) * 2000-07-11 2003-02-14 Oreal Composition a base de vitamines et de sels mineraux, pour diminuer la chute des cheveux et/ou favoriser la repousse des cheveux
US7829709B1 (en) 2007-08-10 2010-11-09 Marquette University Cysteine prodrugs to treat schizophrenia and drug addiction
US8173809B2 (en) 2008-02-07 2012-05-08 Marquette University Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings
CA2871774C (en) * 2012-04-26 2021-05-18 Sentient Lifesciences, Inc. Use of n-acetylcysteine amide in the treatment of disease and injury
WO2018174839A1 (en) * 2017-03-18 2018-09-27 Nguyen Mark Quang Cysteine, n-acetylcysteine and penicillamine prodrugs, pharmaceutical compositions thereof, and methods of use
WO2021092470A1 (en) * 2019-11-08 2021-05-14 Retina Foundation Of The Southwest Compounds and implants for treating ocular disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4619M (it) * 1965-02-01 1966-11-28
BE744952A (en) * 1969-01-28 1970-07-27 Bristol Myers Co Treatment to maintain the urinary - passages clear
JPS5592315A (en) * 1979-01-05 1980-07-12 Santen Pharmaceut Co Ltd Remedy for cataract
JPS5649879A (en) * 1979-10-01 1981-05-06 Furukawa Electric Co Ltd Electrically heating furnace
BE901885A (fr) * 1985-03-06 1985-07-01 Bruschettini Srl Composition pharmaceutique sous forme de lotion ophtalmique et son procede de preparation.
US4708965A (en) * 1985-09-16 1987-11-24 Morgan Lee R Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives
WO1988000182A1 (en) * 1986-07-07 1988-01-14 Teijin Limited gamma-L-GLUTAMYL-L-CYSTEINE ETHYL ESTER AND DRUG CONTAINING IT AS EFFECTIVE INGREDIENT
FR2651129B1 (fr) * 1989-08-31 1991-12-13 Bfb Etud Rech Eperimentales Nouveaux derives de cysteine; compositions pharmaceutiques ou cosmetiques en contenant.

Also Published As

Publication number Publication date
US5519054A (en) 1996-05-21
ITMI910456A0 (it) 1991-02-21
ITMI910456A1 (it) 1992-08-21
ATE151288T1 (de) 1997-04-15
DE69218816T2 (de) 1997-07-17
EP0499882B1 (en) 1997-04-09
JPH0585933A (ja) 1993-04-06
DE69218816D1 (de) 1997-05-15
EP0499882A1 (en) 1992-08-26
JP3457687B2 (ja) 2003-10-20

Similar Documents

Publication Publication Date Title
AP2000001860A0 (en) Hypolipidemic benzothiazepine compounds.
EP0564739A3 (it)
EE03969B1 (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
SE8300736D0 (sv) Novel pharmacologically active compounds
DE59309786D1 (de) Enniatine und enniatinderivate zur bekämpfung von endoparasiten
IT1249047B (it) Composizione farmaceutica per il trattamento della cataratta
NO890259L (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
AR012294A1 (es) Derivados de sulfonamida, un procedimiento para su preparacion, composiciones farmaceuticas que los contienen, uso de dichos derivados para lapreparacion de un medicamento.
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
MX9203417A (es) Compuestos de diarilo antiateroescleroticos.
ATE180781T1 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
BR0111678A (pt) Composições medicinais contendo derivados de propenona
SE8404065D0 (sv) Novel biologically active compounds
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
IT1270905B (it) Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
SE8600658D0 (sv) Novel composition of matter
IL99471A0 (en) Pharmaceutical compositions containing pyridylmethylsulphinyl-1h-benzimidazole derivatives as active ingredient therein
MX9203361A (es) Composiciones farmaceuticas que contienen cloruro de galio.
NO880406L (no) 5-(3-alkyl-5-tert-butyl-4-hydroksyfenyl)-2-amino-6h-1,3,4-tiadiaziner, fremgangsmaate til deres fremstilling og legemidler som inneholder dem og deres anvendelse.
IL89335A (en) 6-oxo-pyridazine derivatives, a process for their preparation and pharmaceutical compositions containing these compounds
ATE231728T1 (de) Pharmazeutische zusammensetzung enthaltend interferon-gamma stimulatoren
AU8114387A (en) Use of 5-(substituted phenyl)-oxazolidinone derivatives for treatment of depression
ES2145926T3 (es) Derivados metalocenicos de diariletileno, metodos de preparacion y composiciones farmaceuticas que contienen estos derivados.
JO1493B1 (en) Pharmaceutical combination for treating high blood pressure

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960123